BIOMAT Database Logo BIOMAT Database Logo

Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells. 1979

N Okada, and H Shibuta, and H Okada

UI MeSH Term Description Entries
D010222 Parainfluenza Virus 1, Human A species of RESPIROVIRUS also called hemadsorption virus 2 (HA2), which causes laryngotracheitis in humans, especially children. Hemadsorption Virus 2,Human parainfluenza virus 1,Para-Influenza Virus Type 1,Parainfluenza Virus Type 1,Para Influenza Virus Type 1
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Okada, and H Shibuta, and H Okada
Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.
May 1983, Immunology,
N Okada, and H Shibuta, and H Okada
Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.
January 1982, The Journal of experimental medicine,
N Okada, and H Shibuta, and H Okada
Sendai virus infected cells are readily cytolysed by guinea-pig complement without antibody.
June 1981, Immunology,
N Okada, and H Shibuta, and H Okada
Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum.
September 1983, Immunology,
N Okada, and H Shibuta, and H Okada
Activation of chicken alternative complement pathway by fowlpox virus-infected cells.
November 1983, Infection and immunity,
N Okada, and H Shibuta, and H Okada
Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.
January 1980, Proceedings of the National Academy of Sciences of the United States of America,
N Okada, and H Shibuta, and H Okada
Activation of homologous complement via the alternative complement pathway by quail cells transformed by Rous sarcoma virus.
October 1995, The Journal of veterinary medical science,
N Okada, and H Shibuta, and H Okada
Activation of the alternative pathway of complement by apoptotic Jurkat cells.
September 1994, FEBS letters,
N Okada, and H Shibuta, and H Okada
Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
January 1980, Annales d'immunologie,
N Okada, and H Shibuta, and H Okada
Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
June 1983, Immunology,
Copied contents to your clipboard!